"Non-toxic" investments may hit European insurers' capital base

While some European firms are still reeling from investments in "toxic" paper, concern is mounting about potential losses in more mainstream holdings, as Sarfraz Thind reports


Germany maps out route to Solvency II

The MaRisk VA circular raises the country's preparations for 2012 to a new level. One result: risk management will become more of a board concern. Report by Jessica Baylis


Why Solvency II is more sophisticated than Basel II

Don't let politically-motivated arguments put you off. Solvency II is our best hope for sound insurance markets, says Munich Re's head of solvency consulting Margarita von Tautphoeus.


Capital erosion isn't a problem for insurers -- yet

The financial crisis hasn't dented re/insurers' capital too badly. Sources of capital remain to be tapped. But pray for a light hurricane season, says Helen Yates.


Reinsurer capital will have dropped 15-20% in 2008

Insurers will have come off even worse as the credit and liquidity crisis takes its toll


Re-rating the rating agencies

The global financial crisis has raised serious questions about the reliability of credit ratings. Helen Yates asks what this means for European insurers and for ratings under Solvency II.


Banks should take model lessons from insurers

The vital element is human judgement, says Hampden Agencies' Alistair Wood


Is the test of use too loose?

Internal models for Solvency II should be fully embedded in the business but official guidance on this is quite vague, says John Ferry


How Peter Ingenlath makes risk work for Atradius

Peter Ingenlath talks about his role as the chief risk officer of credit risk insurer Atradius and why he takes a positive view of risk.


Time to get serious about the models

Only forty-seven months to Solvency II! For insurers taking the internal model route crucial decisions are needed now. Jessica Baylis reports.